Harrison.ai is Transforming Healthcare with $121.1 M Funding

AI-led innovation is dramatically changing the landscape of healthcare worldwide with Harrison.ai at the forefront of this transformation. On a mission to urgently scale the capacity of global healthcare, the clinician-led company in Australia has been using AI automation to make remarkable progress, especially in the realm of In Vitro Fertilization (IVF). Harrison.ai recently secured funding of $121.1 million and has committed to leveraging deep learning so it can revolutionize existing healthcare by improving the success rate of IVF procedures. 

Harrison.ai recognizes the challenges faced by the healthcare system currently, including inconsistent treatment and strained capacity. A dearth of skills combined with the increasing demand for healthcare poses a serious threat to the quality of service clinicians can provide. To tackle this challenge, Harrison.ai is employing ultra-modern artificial intelligence to collaborate with healthcare specialists and deliver cutting-edge diagnostic solutions. 

Addressing Challenges in Healthcare

Headquartered in the rural locality of Barongarook in Victoria, Australia, Harrison.ai was founded by two brothers, Dimitry Tran and Aengus Tran, in 2018. The company provides customized AI-enabled tools that can be readily integrated by healthcare providers into their clinical workflows. In doing so, Harrison.ai is able to empower clinicians and contribute towards better patient outcomes, both of which are important aspects of its overarching mission.

One of the company’s unique features is its IVY deep learning model. This model examines the complete five-day video footage from an embryo scope, surpassing the performance of AI tools relying on still images even today. Harrison.ai utilizes the deskside DGX Station to experiment, research, and develop cutting-edge technology that helps in its pursuit of groundbreaking healthcare solutions. 

Harrison.ai products

(Image source: I-MED Radiology Network)

Funding and Investors

Having raised a total of $121.1 million across two funding rounds, Harrison.ai is presently backed by six investors. Horizons Ventures and Skip Capital are the most recent funders to have joined the venture, which underscores the company’s confidence in its vision and potential to reshape the landscape of global healthcare forever. 

Even though it solely focussed on improving IVF outcomes initially, Harrison.ai has now expanded its reach to medical imaging through a joint venture with I-MED, Australia’s largest radiology network. The partnership was forged in early 2020 and has resulted in the development of Annalise.AI, a tool that enhances the efficiency and accuracy of medical diagnostics, particularly chest x-rays. 

Transformative Impact of Medical Imaging

In response to the challenges that surfaced during the COVID-19 pandemic, Harrison.ai made significant progress with Annalise.AI. This AI tool is used to detect more than 120 findings in chest x-rays in a matter of seconds. The use of Annalise.AI not only reduces the pressure faced by clinicians but also improves health outcomes for patients by expediting the diagnosis of conditions such as trauma, cancer, and heart disease. 

The success of Annalise.AI Enterprise CXR was marked by its nomination as a final contender in the InnovationAus 2023 Awards for Excellence in the category of Health Tech. The tool’s ability to automatically detect suspected locations of x-ray findings has garnered acclaim for contributing to the efficiency of radiologists worldwide.

Harrison.ai co-founders Dimitry Tran and Aengus Tran

(Image source: Blackbird VC)

Future Outlook

Harrison.ai’s commitment to constant innovation combined with the commercialization of effective and affordable healthcare products and services positions the company as a key player in the ever-evolving landscape of healthcare. As artificial intelligence continues to play an integral role in healthcare, Harrison.ai is preparing to contribute in more significant ways to improve patient outcomes and alleviate the challenges plaguing healthcare systems globally. 

Harrison.ai’s extraordinary journey from strengthening the success rate of IVF procedures to making impressive advancements in medical imaging exemplifies the true potential of artificial intelligence in healthcare. With its clear mission, robust funding, and strategic partnerships, the company has built a firm foundation and is confident about furthering its mission to scale healthcare capacity worldwide through novel AI solutions. As Harrison.ai continues to grow, it is expected to have a profound and widespread impact on global healthcare.